4Kscore® Test Accurately Predicts Aggressive Prostate Cancer in Second U.S. Prospective Study

Results Indicate Effectiveness of 4Kscore Test for All Men, Including African American Men A prospective study conducted at various institutions within the U.S. Veteran’s Affairs (VA) Health System has found the 4Kscore Test accurately predicted the risk for aggressive prostate cancer in men prior to biopsy. The results of this study confirm the findings of […]


To Maintain Good Health, Be Proactive

Would you drive your car for two years without checking the oil? Some men wait more than two years between physician visits. Would you put off updating your smart phone until it stopped working? Many men endure symptoms until severe pain finally drives them to seek treatment. Most men recognize the importance of regular maintenance […]


Who is the Ideal Candidate for the 4Kscore Test?

The 4Kscore is a simple blood test which analyzes four prostate-specific biomarkers in the blood along with clinical information. The results of the 4Kscore test provide each patient with a personalized, accurate measurement of their risk for having aggressive prostate cancer; information which can be used to help in the biopsy decision making process. Are […]


4Kscore featured on UroToday: AUA 2017

AUA 2017 just wrapped up in Boston, MA. On Sunday May, 14, Dr. Karim Marzouk and colleagues from Memorial Sloan Kettering Cancer Center presented a poster titled “Combining 4Kscore and MRI for Prostate Biopsy Decision Making”. The session highlighted the findings from the recently published PROMIS MRI trial, utilizing the multiparameteric MRI (mpMRI) as a […]

Press Release

OPKO Health’s 4Kscore® Test Highlighted in Podium Presentation at 112th American Urological Association Annual Meeting

Prospective study conducted at Veteran Affairs hospitals confirms 4Kscore accurately predicts aggressive prostate cancer MIAMI, May 18, 2017 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ:OPK), announces that data from a prospective study conducted at Veteran Affairs (VA) hospitals confirming the 4Kscore test’s ability to accurately predict aggressive prostate cancer were presented in a podium presentation […]

Press Release

OPKO Announces Multiple Presentations at the 112th AUA Annual Meeting

Highlights 4Kscore’s ability to predict aggressive prostate cancer Showcasing 4Kscore and Claros 1 Point-of-Care System at Exhibit Booth #904 MIAMI, May 15, 2017 (GLOBE NEWSWIRE) — OPKO Health, Inc. (Nasdaq:OPK) announces that multiple podium and poster presentations highlighting the Company’s 4Kscore test will be presented at the 112th American Urological Association (AUA) Annual Meeting taking […]